PREDNISONE TABLETS
IgA Glomerulonephritis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Small moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the IgA Glomerulonephritis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
VALSARTAN Columbia University | Phase 4 | BB |
BARDOXOLONE METHYL ESTER Biogen | Phase 2 | B |
Aliskiren Columbia University | Phase 4 | CCC |
Ucar T-Cell The Children's Hospital of Zhejiang University School of Medicine | Phase 1 | CCC |
qt-219cx The Children's Hospital of Zhejiang University School of Medicine | Early Phase 1 | C |
RD06-05 CART Cell The Children's Hospital of Zhejiang University School of Medicine | Early Phase 1 | C |
Enalapril National Center for Research Resources (NCRR) | N/A | D |
Same molecule, other indications
PREDNISONE TABLETS is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →